Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties

Journal of Leukocyte Biology

Volumn 89, Issue 2, 2011, Pages 311-317

  Brandau, Sven ^a   Trellakis, Sokratis ^a   Bruderek, Kirsten ^a   Schmaltz, Dominik ^b   Steller, Gabriele ^b   Elian, Motaz ^a   Suttmann, Henrik ^c   Schenck, Marcus ^a   Welling, Jürgen ^b   Zabel, Peter ^b   Lang, Stephan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bladder cancer; Head and neck cancer; Lung cancer; Neutrophil precursors

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; GAMMA INTERFERON;

ADULT; ARTICLE; BLADDER CANCER; CANCER PATIENT; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY GRADIENT; EFFECTOR CELL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LUNG CANCER; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEDIMENTATION; SUPPRESSOR CELL; URETER CANCER;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMOTAXIS, LEUKOCYTE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYELOID PROGENITOR CELLS; NEUTROPHILS; TUMOR CELLS, CULTURED;

MUS;

EID: 79951823584     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0310162     Document Type: Article

References (36)

1. Gabrilovich, D. (2004) Mechanisms and functional significance of tumor-induced dendritic-cell defects. Nat. Rev. Immunol. 4, 941-952.
2. Young, M. R., Wright, M. A., Lozano, Y., Prechel, M. M., Benefield, J., Leonetti, J. P., Collins, S. L., Petruzzelli, G. J. (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int. J. Cancer 74, 69-74. (Pubitemid 27157858)
3. Ostrand-Rosenberg, S., Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499-4506.
4. Serafini, P., Borrello, I., Bronte, V. (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16, 53-65. (Pubitemid 43139709)
5. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
6. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802.
7. Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., Matsushima, K. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457-5466.
8. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233-4244.
9. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez, G. A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., Bronte, V. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40, 22-35.
10. Talmadge, J. E. (2007) Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin. Cancer Res. 13, 5243-5248.
11. Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D. I. (2004) Antigenspecific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172, 989-999. (Pubitemid 38113758)
12. Ochoa, A. C., Zea, A. H., Hernandez, C., Rodriguez, P. C. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13, 721s-726s.
13. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182, 5693-5701.
14. Kusmartsev, S., Gabrilovich, D. I. (2006) Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol. Immunother. 55, 237-245. (Pubitemid 41683212)
15. Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., Ochoa, A. C. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69, 1553-1560.
16. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F., Korangy, F. (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135, 234-243. (Pubitemid 351899008)
17. Almand, B., Clark, J. I., Nikitina, E., van Beynan, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689. (Pubitemid 32038493)
18. Kusmartsev, S., Su, Z., Heiser, A., Dannull, J., Eruslanov, E., Kubler, H., Yancey, D., Dahm, P., Vieweg, J. (2008) Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 14, 8270-8278.
19. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., Bicciato, S., Bronte, V. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD86 T cells. J. Clin. Invest. 116, 2777-2790. (Pubitemid 44511641)
20. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A., Rossi, C. R., Nitti, D., Bronte, V., Zanovello, P. (2009) IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 182, 6562-6568.
21. Suttmann, H., Riemensberger, J., Bentien, G., Schmaltz, D., Stockle, M., Jocham, D., Bohle, A., Brandau, S. (2006) Neutrophil granulocytes are required for effective bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res. 66, 8250-8257. (Pubitemid 44299194)
22. Schmielau, J., Finn, O. J. (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760. (Pubitemid 32691887)
23. Goddard, D. S., Yamanaka, K., Kupper, T. S., Jones, D. A. (2005) Activation of neutrophils in cutaneous T-cell lymphoma. Clin. Cancer Res. 11, 8243-8249. (Pubitemid 41746933)
24. Skubitz, K. M., Campbell, K. D., Skubitz, A. P. (1996) CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J. Leukoc. Biol. 60, 106-117. (Pubitemid 26248889)
25. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., Montero, A. J. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49-59.
26. Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., Rivoltini, L. (2007) Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546-2553. (Pubitemid 47041228)
27. Wright, S. D., Ramos, R. A., Hermanowski-Vosatka, A., Rockwell, P., Detmers, P. A. (1991) Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173, 1281-1286.
28. Hänsch, G. M., Wagner, C. (2003) Expression of MHC class II antigen and coreceptor molecules in polymorphonuclear neutrophils. Chem. Immunol. Allergy 83, 45-63. (Pubitemid 37522411)
29. Elghetany, M. T. (2002) Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis. 28, 260-274.
30. Fujimoto, H., Sakata, T., Hamaguchi, Y., Shiga, S., Tohyama, K., Ichiyama, S., Wang, F. S., Houwen, B. (2000) Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry 42, 371-378. (Pubitemid 32047567)
31. Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., Plaetinck, G. (1991) A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 66, 1175-1184. (Pubitemid 121001407)
32. Hirai, H., Zhang, P., Dayaram, T., Hetherington, C. J., Mizuno, S., Imanishi, J., Akashi, K., Tenen, D. G. (2006) C/EBPβ is required for "emergency" granulopoiesis. Nat. Immunol. 7, 732-739.
33. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 32, 790-802.
34. Cassatella, M. A. (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73, 369-509.
35. Murphy, P. M. (1997) Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 34, 311-318.
36. Eash, K. J., Means, J. M., White, D. W., Link, D. C. (2009) CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113, 4711-4719.